A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis

To compare the efficacy and safety of To compare the efficacy and safety of gatifloxacin ophthalmic solution 0.3% (Zymar) administered BID versus QID in patients with acute bacterial conjunctivitis. In a randomized, investigator-masked clinical trial, patients diagnosed with bacterial conjunctivitis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current medical research and opinion 2005-03, Vol.21 (3), p.425
Hauptverfasser:	Yee, Richard W, Tepedino, Michael, Bernstein, Paula, Jensen, Harold, Schiffman, Rhett, Whitcup, Scott M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Administration, Oral Adult Conjunctivitis, Bacterial - drug therapy Female Fluoroquinolones - adverse effects Fluoroquinolones - therapeutic use Humans Male Middle Aged Ophthalmic Solutions Single-Blind Method Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!